Skip to main content
. 2015 Jul 6;33(23):2530–2536. doi: 10.1200/JCO.2015.61.3026

Table 4.

Receipt of Select Chemotherapy Agents and Combination Chemotherapy Regimens by Race Among Patients With Stage III Colon Cancer Who Were Diagnosed in 2005 and 2010 and Treated With Adjuvant Chemotherapy

graphic file with name zlj02315-5396-t04.jpg

Chemotherapy NH White (n = 159)
 NH Black (n = 130)
Weighted %* SE Weighted %* SE
Agents (any)†
    FU 90.1 2.69 83.0 3.27
    Oxaliplatin 73.9 4.70 76.4 3.97
    Capecitabine 14.5 3.34 16.2 3.52
Regimens
    FU + leucovorin 14.8 3.80 7.5 2.81
    FOLFOX 69.8 4.82 68.0 4.00
    Capecitabine alone 5.2 2.29 4.6 1.60
    CapeOx 2.8 1.15 4.4 1.99

Abbreviations: FU, fluorouracil; CapeOx, capecitabine and oxaliplatin; FOLFOX, fluorouracil, leucovorin, and oxaliplatin; NH, non-Hispanic.

*

Proportion weighted by sampling fraction.

†

Chemotherapy agents not mutually exclusive.